Timing of CAR-T therapy in follicular lymphoma

被引：0
|
作者：
Moustafa, Muhamad Alhaj [1 ]
机构：
[1] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2023年 / 23卷 / 04期
关键词：
Follicular lymphoma; CAR T therapy; relapsed; refractory; RITUXIMAB; RISK;
D O I：
10.1080/14737140.2023.2185222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：347 / 349
页数：3
相关论文
共 50 条
  • [21] Tisagenlecleucel: CAR-T Cell Therapy for B-cell Lymphoma
    Andres, Ulrike
    TRANSFUSIONSMEDIZIN, 2019, 9 (02)
  • [22] CONTROLLING CAR-T THERAPY
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (19) : 32 - 37
  • [23] CAR-T cell therapy
    San Segundo, Lucrecia Yanez
    MEDICINA CLINICA, 2021, 156 (03): : 123 - 125
  • [24] Prognosis Score for Overall Survival with CAR-T Therapy in Aggressive Lymphoma
    Bansal, Radhika
    Khurana, Arushi
    Jankowski, Matthew
    Hathcock, Matthew A.
    Bennani, N. Nora
    Paludo, Jonas
    Wang, Yucai
    Durani, Urshila
    Hampel, Paul J.
    Ansell, Stephen M.
    Johnston, Patrick B.
    Lin, Yi
    BLOOD, 2022, 140 : 9504 - 9505
  • [25] Lymphoma immunotherapy: Efficacy, safety, and accessibility to CAR-T therapy for lymphomas
    Borchmann, Peter
    HEMASPHERE, 2018, 2 : 93 - 95
  • [26] The Evolving Use of CAR T-Cell Therapy in Follicular Lymphoma
    Nastoupil, Loretta J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 684 - 686
  • [27] Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy
    Rivas-Delgado, Alfredo
    Luttwak, Efrat
    Drill, Esther
    Goldstein, Ilan
    Landego, Ivan
    Tomas, Ana Alarcon
    Parascondola, Allison
    Saldia, Amethyst
    Caron, Philip
    Dahi, Parastoo B.
    Epstein-Peterson, Zachary D.
    Falchi, Lorenzo
    Hamlin, Paul A.
    Johnson, William
    Kumar, Anita
    Lin, Richard J.
    Lue, Jennifer Kimberly
    Owens, Colette
    Noy, Ariela
    Scordo, Michael
    Dogan, Ahmet
    Seshan, Venkatraman
    Zelenetz, Andrew D.
    Perales, Miguel-Angel
    Shouval, Roni
    Palomba, Maria Lia
    Shah, Gunjan L.
    Salles, Gilles
    BLOOD, 2023, 142
  • [28] Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disorders
    Bachanova, Veronika
    Nachman, Patrick H.
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1175 - 1176
  • [29] CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma
    Ostojska, Magdalena
    Nowak, Emilia
    Twardowska, Julia
    Lejman, Monika
    Zawitkowska, Joanna
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [30] Phase 2 trial has started for CAR-T therapy in lymphoma patients
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (05) : 1090 - 1090
12345